The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Improving antibody affinity by mimicking somatic hypermutation in vitro
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rapid and efficient site-specific mutagenesis without phenotypic selection.
Kunkel, T. A. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.2.488 · Cited by 7,206
Maloney, D. G., Grillo-López, A. J., White, C. A., Bodkin, D., Schilder, R. J., Neidhart, J. A., Janakiraman, N., Foon, K. A., Liles, T.-M., Dallaire, B. K., et al. (1997) · Blood · doi:10.1182/blood.v90.6.2188 · Cited by 1,733
Baselga, J. M., Norton, L., Albanell, J., Kim, Y. M., & Mendelsohn, J. M. (1998) · PubMed · Cited by 996
Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms.
Yokota, T., Milenic, D. E., Whitlow, M. D., & Schlom, J. (1992) · PubMed · Cited by 819
Chang, K., & Pastan, I. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.136 · Cited by 745
Self-citationPhysiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors.
Jain, R. K. (1990) · PubMed · Cited by 574
Osterborg, A., Dyer, M. J., Bunjes, D., Pangalis, G. A., Bastion, Y., Catovsky, D., & Mellstedt, H. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.4.1567 · Cited by 512
Human anti-self antibodies with high specificity from phage display libraries.
Griffiths, A. D., Malmqvist, M., Marks, J. D., Bye, J. M., Embleton, M. J., McCafferty, J., Baier, M., Holliger, K. P., Gorick, B. D., & Hughes-Jones, N. C. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05706.x · Cited by 478
Somatic hypermutagenesis in immunoglobulin genes
Rogozin, I. B., & Kolchanov, N. A. (1992) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(92)90134-l · Cited by 454
Design and Use of a Phage Display Library
Pini, A., Viti, F., Santucci, A., Carnemolla, B., Zardi, L., Neri, P., & Neri, D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.34.21769 · Cited by 422
Cited by
Antibody-Based Bio-Nanotube Membranes for Enantiomeric Drug Separations
Lee, S. B., Mitchell, D. T., Trofin, L., Nevanen, T. K., Söderlund, H., & Martin, C. R. (2002) · Science · doi:10.1126/science.1071396 · Cited by 619
Pastan, I., Hassan, R., FitzGerald, D. J., & Kreitman, R. J. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1891 · Cited by 528
Self-citationHassan, R., Bera, T., & Pastan, I. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0801 · Cited by 441
Self-citationHassan, R., Bullock, S., Premkumar, A., Kreitman, R. J., Kindler, H., Willingham, M. C., & Pastan, I. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0869 · Cited by 379
Self-citationImmunotoxin Treatment of Cancer
Pastan, I., Hassan, R., FitzGerald, D. J., & Kreitman, R. J. (2007) · Annual Review of Medicine · doi:10.1146/annurev.med.58.070605.115320 · Cited by 359
Self-citationMesothelin targeted cancer immunotherapy
Hassan, R., & Ho, M. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2007.08.028 · Cited by 340
Mesothelin Immunotherapy for Cancer: Ready for Prime Time?
Hassan, R., Thomas, A., Alewine, C., Le, D. T., Jaffee, E. M., & Pastan, I. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.68.3672 · Cited by 325
Self-citationHassan, R., Remaley, A. T., Sampson, M. L., Zhang, J., Cox, D. D., Pingpank, J., Alexander, R., Willingham, M., Pastan, I., & Onda, M. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1477 · Cited by 296
Self-citationCollis, A. V. J., Brouwer, A. P., & Martin, A. C. R. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)01222-6 · Cited by 256
Discovery of Mesothelin and Exploiting It as a Target for Immunotherapy
Pastan, I., & Hassan, R. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0337 · Cited by 252
Self-citationKoenig, P., Lee, C. V., Walters, B. T., Janakiraman, V., Stinson, J., Patapoff, T. W., & Fuh, G. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1613231114 · Cited by 107
Hu, D., Hu, S., Wan, W., Xu, M., Du, R., Zhao, W., Gao, X., Liu, J., Liu, H., & Hong, J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0129125 · Cited by 86
“Novel strategies to improve CDR diversification efficiency have been reported, such as hot-spot mutagenesis [6], look-through mutagenesis [7], simultaneous mutagenesis [8], and small perturbation mutagenesis (SPM) which was recently developed by our group [9].”
BackgroundStructures of Cancer Antigen Mesothelin and Its Complexes with Therapeutic Antibodies
Zhan, J., Lin, D., Watson, N., Esser, L., Tang, W. K., Zhang, A., Liu, X., Hassan, R., Gleinich, A., Shajahan, A., et al. (2023) · Cancer Research Communications · doi:10.1158/2767-9764.crc-22-0306 · Cited by 28
Self-citationIn Vitro Antibody Affinity Maturation Targeting Germline Hotspots
Ho, M., & Pastan, I. (2009) · Methods in Molecular Biology™ · doi:10.1007/978-1-59745-554-1_15 · Cited by 21
“We have developed an approach, called “hotspot mutagenesis”, using PCR and phage display to randomize germline hotspots to increase antibody affinity specific for various tumor antigens (4-7).”
BackgroundMethodSelf-citation
Metadata
- Authors
- Chowdhury, P. S., & Pastan, I.
- Venue
- Nature Biotechnology
- Published
- 1999-06
- Volume
- 17
- Issue
- 6
- Pages
- 568-572
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- DOI
- 10.1038/9872
- OpenAlex
- W1607832269
- Cited by
- 256
- References
- 35
- FWCI
- 10.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.